ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

PYM Phytopharm

58.00
0.00 (0.00%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Phytopharm LSE:PYM London Ordinary Share GB00BCLY7L40 ORD 50P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 58.00 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Phytopharm Share Discussion Threads

Showing 3676 to 3697 of 3825 messages
Chat Pages: 153  152  151  150  149  148  147  146  145  144  143  142  Older
DateSubjectAuthorDiscuss
18/2/2013
13:34
Mrs Ape, sorry about today. As you know i bought in very recently, only a small amount as i was wary of the decline on around 11th Jan on no news and quite high vols, thought it could poss have been a mini leak of bad news around then, but then price recovered. I sold on Friday, i just couldn't see buyers really committing on Thurs/Fri, and maybe i was lucky here, it looked to be forming a Wave 2 post Wave one, but the Wave 2 was looking more and more like a triangle, which you never get as a Wave two, that was catalyst to bail. Investing in AIM stocks is like being an extra in the Hurt Locker, Bombs everywhere, but some Gems. So far no bombs, but no doubt one will hit sooner or later, has to happen. PS i did end up selling the small holding in Summit.
melodrama
18/2/2013
13:25
could go to 1p in the afternoon
binladin
18/2/2013
13:09
1242 GMT [Dow Jones] Phytopharm (PYM.LN) shares have slumped more than 81% to 1.88p after a disappointing update of the phase II trial of Cogane. Edison Investment Research says the drug now faces a bleak future. "The failure of Cogane to demonstrate a neuro-protective/regenerative effect in its most comprehensive clinical study does not bode well for attracting further investment in amyotrophic lateral sclerosis," it says. Adds that, given a lack of viable alternative pipeline options, the company's key assets now appear to be its cash reserve, a full listing on the London Stock Exchange and GBP55M in accumulated tax losses. (nina.bains@dowjones.com)


Tax losses will attract a buyer imho

alchemy30
18/2/2013
11:19
nothing better than Binladin losing money.
duncandisorderly
18/2/2013
11:06
worth 1.5p imo,,,
binladin
18/2/2013
10:59
good point bin.
induna123
18/2/2013
10:57
yes they have burnt the cash but the knowledge thsat these companies have acquired is worth something to the pharma giants,that is where the value is and it will stop the big pharmas from making the same mistakes themselves...
in effect they could start where these boys finished together with their own research dept..

binladin
18/2/2013
10:52
AIM start up pharmas are the PI graveyard......happens again and again...cash burn, placing, test results, more cash burn, placing, more test results, more cash burn, more placings until the gravy train runs out of steam...
monkey puzzle
18/2/2013
10:51
Simon, look for a dead cat bounce. You know about supply and demand, tight spreads, overhangs ect...
induna123
18/2/2013
10:48
KNIGEL

That means nothing to a Bio, cash burn will be high, what happens if they shut down, will be plenty of costs, I cannot see any value now.

34simon
18/2/2013
10:48
so it worth 3,5p with cash and good will as a trading concern.....
binladin
18/2/2013
10:45
Got some at 1.95p as this is below CASH NAV of circ 2.5p if you read the last results GLA
knigel
18/2/2013
10:38
straight up now to 3p........looks like big buyers in the background......
binladin
18/2/2013
10:33
Yet another truely awful P&D from TopFlop and Co......biter got bit badly this time though....they need another big P&D to make up for this one.
monkey puzzle
18/2/2013
10:18
i reckon a quick takeover by glaxo or norvartis could be in the pipline...
taking out competitors in a ruthless business is the thing to do...

binladin
18/2/2013
10:14
if it is same a placebo then its not a failure...
binladin
18/2/2013
10:07
You don't care what cash they have. All you are looking for is a dead cat bounce to make a quick 100% profit. You may get it, you may not.
induna123
18/2/2013
10:05
Topinfo's posts on his thread are funny, he will try and wriggle out of any disaster call wont he !
34simon
18/2/2013
10:02
they have enough money until march 2014.
binladin
18/2/2013
10:01
big shame.

it is almost a one trick pony.

The accumulated tax losses are worth 3p a share. The ALS program may surprise.

Ive got a personal enterprise value now of 5p per share. but that assumes several things. Good Luck all. (mostly institutions that got burned)

mrsapeslaptop
18/2/2013
09:58
LOL, binladin just bought into a one trick pony who's trick doesn't work.
induna123
18/2/2013
09:55
the above is shorter...wanting to screw the co even more..
binladin
Chat Pages: 153  152  151  150  149  148  147  146  145  144  143  142  Older

Your Recent History

Delayed Upgrade Clock